Illumina v Element Biosciences (CFI, 16 October 2026)
| Date | 16 October 2026 |
|---|---|
| Court | CFI |
| Division | Lisbon (PT) Local Division |
| Type of action | Infringement Action |
| Case number(s) | UPC_CFI_1920/2025, UPC_CFI_1060/2026 |
| Registry reference | UPC-CFI-0001920/2025 |
| Parties | Illumina, Inc. v. Element Biosciences, Inc., Element Biosciences Netherlands B.V., Instrumentos de Laboratório e Científicos, LDA |
| Language | English |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 22 October 2026
Our analysis
Summary
By an order of 16 October 2026 following the interim conference (Rule 105.5 RoP), the judge-rapporteur of the Lisbon Local Division, in the dispute between Illumina, Inc. and Element Biosciences, Inc., Element Biosciences Netherlands B.V. and I.L.C. Instrumentos de Laboratório e Científicos Lda (UPC_CFI_1920/2025 and UPC_CFI_1060/2026, EP 3 714 978), set the value of the infringement action at EUR 8,000,000 and that of the counterclaim for revocation at EUR 12,000,000, and laid down the arrangements for the oral hearing to be held in Lisbon on 17 December 2026.
Question
What can the interim conference settle ahead of the oral hearing as regards the value of the dispute, the scope of the claim construction and validity debate, and the conduct of the hearing?
Decision
On the basis of the parties’ agreement, the judge-rapporteur set the value of the infringement action at EUR 8,000,000 and that of the counterclaim for revocation at EUR 12,000,000, giving EUR 20,000,000 for the proceedings as a whole and a ceiling for recoverable costs of EUR 1,200,000 (paras 6 to 8). The claim construction debate is confined to features 1.4.2 and 1.4.7.2, whose reading also determines literal infringement (para 12). Seven validity attacks will be argued, and the admissibility of a new added matter attack raised in the Defendants’ Reply is left to the panel (paras 13 and 14). The number of auxiliary requests, 23 in total, was not considered unreasonable given their structure (para 16). The Claimant must clarify its allegations of direct and indirect infringement within two weeks, with an equal period for the Defendants to respond (para 17 and operative part). The order also sets a timed agenda for the hearing and deadlines for filing presentations and lists of attendees (paras 19 to 25 and operative part).
Key points for practice
- The judge-rapporteur asked the Defendants whether they would make their counterclaim for revocation conditional upon a finding of infringement, and they agreed to consider it (para 11).
- Since the auxiliary requests are built around three features (location sensor, fluidic device, support beams), the parties will argue feature by feature rather than request by request (para 16).
Provisions applied
- Rules of Procedure
- Rules 104, 105, 105.5 and 106 RoP
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 22 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Oral procedure and hearing (UPC), Court fees and costs (UPC), Claim interpretation, Pre-trial phase and pre-trial judge.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- English from the language of proceedings
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
UPC_CFI_1920/2025official numberUPC_CFI_1060/2026official number
Parties
- defendantElement Biosciences, Inc.3 decisions in the corpusFollow this party
- claimantIllumina, Inc.2 decisions in the corpusFollow this party
- defendantElement Biosciences Netherlands B.V.2 decisions in the corpusFollow this party
- defendantInstrumentos de Laboratório e Científicos, LDA2 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 1 April 2026 Illumina v Element Biosciences (CFI, 1 April 2026) Infringement Action · UPC_CFI_1920/2025
La demande de rejet de l'action fondée sur la règle 361 est rejetée et le mémoire en demande corrigé remplace le mémoire initial, les défenderesses pouvant répondre sous 10 jours.
- 22 June 2026 Illumina v Element Biosciences (CFI, 22 June 2026) Infringement Action · UPC_CFI_1920/2025
La formation instruira ensemble l’action en contrefaçon et la demande reconventionnelle en nullité. La conférence intermédiaire est fixée au 16 octobre 2026 et l’audience au 17 décembre 2026.
- 16 October 2026 Illumina v Element Biosciences (CFI, 16 October 2026) Infringement Action · UPC_CFI_1920/2025, UPC_CFI_1060/2026
What the record states
- Nature of the act
- Infringement Action
- Outcome (Dhenne Avocats summary)
- La juge rapporteure fixe la valeur de l'action en contrefaçon à 8 millions d'euros et celle de la demande reconventionnelle en nullité à 12 millions d'euros, et arrête l'organisation de l'audience du 17 décembre 2026.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 3 714 978mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Illumina v Element Biosciences (CFI, 22 June 2026) cited in this record
- Illumina v Element Biosciences (CFI, 1 April 2026) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 3 714 978 | Mentioned in the analysis (role not qualified) Also mentioned in 2 other decision(s): Illumina v Element Biosciences (CFI, 22 June 2026) · Illumina v Element Biosciences (CFI, 1 April 2026) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.